Search - tctmd.com

Displaying 81 - 100 of 3147

Sort: Relevancy | Date

Presentation TCT 2025

The DurAVRTM Biomimetic TAVR System in Patients with Small Aortic Annuli (Anteris): One-Year Clinical and Hemodynamic Outcomes

Presenter: Rishi Puri

October 27, 2025

Presentation TCT 2025

Is the WIN ratio always a “Winner”: Where It’s Useful, Where It’s Not

Presenter: John Gregson

October 27, 2025

Presentation TCT 2025

The SIEGEL™ TAVR System: 30-Day US Early Feasibility Study Results (Mirus Medical)

Presenter: Pradeep K. Yadav

October 27, 2025

Presentation TCT 2025

Featured Clinical Research: Aortic Valve Area Reduction: A Novel Concept to Quantify Aortic Stenosis Severity

Presenter: Miho Fukui

October 27, 2025

Presentation TCT 2025

Adaptive and Sequential Designs: From Concept to Execution

Presenter: Graeme L. Hickey

October 27, 2025

Presentation TCT 2025

The Next Generation WATCHMAN Device

Presenter: Michael Joseph Rinaldi

October 27, 2025

Presentation TCT 2025

CHAMPION-AF and the Future of LAAC

Presenter: Chetan Huded

October 27, 2025

Presentation TCT 2025

SIMPLAAFYing the Post-Implant Drug Regimen

Presenter: Christine J. Chung

October 27, 2025

Presentation TCT 2025

Venstramedical

Presenter: Suku T. Thambar

October 27, 2025

Presentation TCT 2025

VITALYST™

Presenter: Robert W. Yeh

October 27, 2025

Presentation TCT 2025

TCT 1084: Impact of Immediate SteNt ImplaNtatiOn Versus Deferred Stent ImplAntaTION on Clinical Outcomes in Patients with AnteRior Wall ST-segment Elevation Myocardial Infarction (INNOVATION-CORE)

Presenter: Cheol Woong Yu

October 27, 2025

Presentation TCT 2025

Magenta

Presenter: Perwaiz M. Meraj

October 27, 2025

Presentation TCT 2025

eCP

Presenter: Navin K. Kapur

October 27, 2025

Presentation TCT 2025

Extravascular, Intrapericardial Mechanical Circulatory Support (MCS): The PSCA System (PercAssist)

Presenter: Mitchell W. Krucoff

October 27, 2025

Presentation TCT 2025

Safety and Feasibility of the Supira System in High-Risk Percutaneous Coronary Interventions: 90-Day Results from the US SUPPORT I Early Feasibility Study (EFS)

Presenter: David E. Kandzari

October 27, 2025

Presentation TCT 2025

Advances in Percutaneous Pump Technologies for Cardiogenic Shock and High Risk PCI

Presenter: Daniel Burkhoff

October 27, 2025

Presentation TCT 2025

Luna™ TMVR: 28-French Transseptal TMVR System: Technology Description and Early Clinical Results

Presenter: Azeem Latib

October 27, 2025

Presentation TCT 2025

TCT 536: Percutaneous Transluminal Caval-flow Regulation PTCR®: An Emerging Innovation to Reduce Total Cardiac Burden in Heart Failure Patients, A Change of Paradigm in the Horizon

Presenter: Jose E. Herrera

October 27, 2025

Presentation TCT 2025

Trans-Apical Intrepid TMVR System: Long Term (5-Year) Technical and Clinical Results

Presenter: Michael J. Reardon

October 27, 2025

Presentation TCT 2025

HighLife TMVR System: Long-Term (3-Year) Clinical Outcomes and Valve Performance of the

Presenter: Wolfgang Rottbauer

October 27, 2025

Advertisement

The DurAVRTM Biomimetic TAVR System in Patients with Small Aortic Annuli (Anteris): One-Year Clinical and Hemodynamic Outcomes

Is the WIN ratio always a “Winner”: Where It’s Useful, Where It’s Not

The SIEGEL™ TAVR System: 30-Day US Early Feasibility Study Results (Mirus Medical)

Featured Clinical Research: Aortic Valve Area Reduction: A Novel Concept to Quantify Aortic Stenosis Severity

Adaptive and Sequential Designs: From Concept to Execution

The Next Generation WATCHMAN Device

CHAMPION-AF and the Future of LAAC

SIMPLAAFYing the Post-Implant Drug Regimen

Venstramedical

VITALYST™

TCT 1084: Impact of Immediate SteNt ImplaNtatiOn Versus Deferred Stent ImplAntaTION on Clinical Outcomes in Patients with AnteRior Wall ST-segment Elevation Myocardial Infarction (INNOVATION-CORE)

Magenta

eCP

Extravascular, Intrapericardial Mechanical Circulatory Support (MCS): The PSCA System (PercAssist)

Safety and Feasibility of the Supira System in High-Risk Percutaneous Coronary Interventions: 90-Day Results from the US SUPPORT I Early Feasibility Study (EFS)

Advances in Percutaneous Pump Technologies for Cardiogenic Shock and High Risk PCI

Luna™ TMVR: 28-French Transseptal TMVR System: Technology Description and Early Clinical Results

TCT 536: Percutaneous Transluminal Caval-flow Regulation PTCR®: An Emerging Innovation to Reduce Total Cardiac Burden in Heart Failure Patients, A Change of Paradigm in the Horizon

Trans-Apical Intrepid TMVR System: Long Term (5-Year) Technical and Clinical Results

HighLife TMVR System: Long-Term (3-Year) Clinical Outcomes and Valve Performance of the

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content